DTL
ALXO icon

Dynamic Technology Lab’s ALX Oncology ALXO Stock Holding History

Dynamic Technology Lab’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,389
Closed -$215K – 1027
2023
Q4 		$215K Buy
+14,389
New +$137K 0.02% 854
2022
Q4 		– Sell
-16,340
Closed -$157K – 1063
2022
Q3 		$157K Buy
+16,340
New +$190K 0.02% 985

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Dynamic Technology Lab's ALXO Position: Q1 2024 in Review

Dynamic Technology Lab sold out of ALX Oncology (ALXO) in Q1 2024, closing a stake of 14,389 shares — an estimated $215K sold.

Dynamic Technology Lab first reported a position in ALXO in Q3 2022 and held it in 2 quarters. The position peaked at $215K in Q4 2023. 106 funds tracked by Wall St. Rank hold ALXO as of Q1 2024.

  • Dynamic Technology Lab reported no remaining ALX Oncology position as of Q1 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 14,389 ALX Oncology shares in Q1 2024, an estimated $215K.
  • Dynamic Technology Lab first reported a position in ALX Oncology in Q3 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's ALX Oncology position peaked at $215K in Q4 2023.
  • 106 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.